Anti‐Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Atherosclerosis is a progressive and multifactorial disease which occurs under the influence of various risk factors including endothelial dysfunction (ED), oxidative stress, and low‐density lipoprotein (LDL) oxidation. In contract to the initial hypotheses on the usefulness of vitamin E supplementation for cardiovascular disease prevention, large outcome trials showed consumption of vitamin E has no obvious effect on cardiovascular disease and, in some cases, it may even increase the rate of mortality. This seemingly unexpected finding may be due to the opposite effects of vitamin E compounds. Vitamin E is a group of compounds which have different and even opposing effects, yet in most of the studies, the exact consumed component of vitamin E is not determined. It appears that the combined consumption of gamma‐tocopherol, vitamin C, D, and tetrahydrobiopterin (BH4) may be extremely effective in both preventing atherogenesis and suppressing plaque development. In this regard, one of main issues is effect of vitamins E and D deficiency on microRNAs network in atherosclerosis. Various studies have indicated that miRNAs have key roles in atherosclerosis pathogenesis. The deficiency of vitamins E and D could provide a deregulation for miRNAs network and these events could lead to progression of atherosclerosis. Here, we highlighted a variety of mechanisms involve in the progression of atherosclerosis and effects of vitamins D and E on these mechanisms. Moreover, we summarized miRNAs involve in atherosclerosis and their regulation by vitamins E and D deficiency. J. Cell. Physiol. 232: 2968–2976, 2017. © 2016 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577 · cited 1×
“For instance, a meta-analysis study has shown that consumption of vitamin E supplement more than 400U/day by adult patients, who had chronic diseases, increases the all-cause mortality (Miller et al., 2005).”
BackgroundRole of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513 · cited 1×
“ED causes damage to the walls of arteries, leading to inflammation (L€uscher and Barton, 1997; Davignon and Ganz, 2004; Deanfield et al., 2007; Pober et al., 2009).”
BackgroundSuperoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Yu, T., Robotham, J. L., & Yoon, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511154103 · Cited by 1,246 · cited 1×
“In addition, factors including hyperglycemia and free fatty acids increase ROS production by mitochondria in EC (Piconi et al., 2006; Yu et al., 2006, 2008; Gremmels et al., 2015).”
BackgroundSesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 2×
“In addition, NFkB also increases the expression of cytokines such as interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF- a) (Collins and Cybulsky, 2001).”
BackgroundLaursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721 · cited 3×
“Anyway, as BH2 competes with BH4 for binding to the eNOS while it cannot act as BH4 to prevent O2 formation (Shinozaki et al., 1999; V asquez-Vivar et al., 2002; Gao et al., 2007) it seems that ONOO may cause eNOS uncoupling through BH4 oxidation (Author) (Fig.”
BackgroundYamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647 · cited 1×
“Another inflammatory effect of ROS is mediated through nuclear factor kB (NFkB) and activator protein-1 (AP-1) activation in ECs (Barchowsky et al., 1995), SMCs (Gloire et al., 2006), and macrophages (Yamamoto et al., 1995).”
BackgroundThe Role of Vitamin E in Human Health and Some Diseases
Rizvi, S., Raza, S. T., Ahmed, F., Ahmad, A., Abbas, S., & Mahdi, F. (2014) · Sultan Qaboos University Medical Journal · doi:10.18295/2075-0528.1566 · Cited by 624 · cited 4×
“…monocyte: PKC inhibition, phosphorylation, and translocation of P47, NADPH oxidase activity LDL oxidation # Cachia et al. (1998); Carr et al. (2000); Rizvi et al. (2014) Gamma—Tocopherol: traps and neutralizes available free available amount of ROS Cholesterol synthesis Tocotrienols: HMG CoA…”
BackgroundInfluentialAmento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609
Yu, T., Sheu, S.-S., Robotham, J. L., & Yoon, Y. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn104 · Cited by 462 · cited 1×
“In addition, factors including hyperglycemia and free fatty acids increase ROS production by mitochondria in EC (Piconi et al., 2006; Yu et al., 2006, 2008; Gremmels et al., 2015).”
BackgroundAsymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396 · cited 1×
“In the absence of L-Arg in the active site of eNOS, electron is transferred to O2 and O2 is produced instead of NO (Cooke, 2004; Maas, 2005) (Fig.”
BackgroundShinozaki, K., Kashiwagi, A., Nishio, Y., Okamura, T., Yoshida, Y., Masada, M., Toda, N., & Kikkawa, R. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2437 · Cited by 329 · cited 2×
“Anyway, as BH2 competes with BH4 for binding to the eNOS while it cannot act as BH4 to prevent O2 formation (Shinozaki et al., 1999; V asquez-Vivar et al., 2002; Gao et al., 2007) it seems that ONOO may cause eNOS uncoupling through BH4 oxidation (Author) (Fig.”
BackgroundGlioblastoma: exosome and microRNA as novel diagnosis biomarkers
Saadatpour, L., Fadaee, E., Fadaei, S., Nassiri Mansour, R., Mohammadi, M., Mousavi, S. M., Goodarzi, M., Verdi, J., & Mirzaei, H. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.48 · Cited by 244 · cited 1×
“These molecules could affect on many cellular and molecular targets (Salarini et al., 2015; Arabpour et al., 2016; Mirzaei, 2016;Mohammadi et al., 2016; Saadatpour et al., 2016).”
BackgroundSelf-citationJanjetovic, Z., Zmijewski, M. A., Tuckey, R. C., DeLeon, D. A., Nguyen, M. N., Pfeffer, L. M., & Slominski, A. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005988 · Cited by 130 · cited 1×
“Consequently, the amount of Ang II is also reduced (Janjetovic et al., 2009; Chen et al., 2013).”
BackgroundZapolska-Downar, D., Zapolski-Downar, A., Markiewski, M., Ciechanowicz, A., Kaczmarczyk, M., & Naruszewicz, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3197 · Cited by 54 · cited 2×
“…expression " Inflammatory condition Alpha—tocopherol: NF-kB inhibition ICAM # Suzuki and Packer (1993); Devaraj and Jialal (1999); Jiang et al. (2000); Zapolska-Downar et al. (2000); Rimbach et al. (2002); Jiang and Ames (2003) VCAM # CD36 # COX-2 # 5-lipoxygenase # IL-1B # Plaque formation…”
Background
Cited by
NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Hoseini, Z., Sepahvand, F., Rashidi, B., Sahebkar, A., Masoudifar, A., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25930 · Cited by 458
Self-citationMicroRNA: A novel target of curcumin in cancer therapy
Mirzaei, H., Masoudifar, A., Sahebkar, A., Zare, N., Sadri Nahand, J., Rashidi, B., Mehrabian, E., Mohammadi, M., Mirzaei, H. R., & Jaafari, M. R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26055 · Cited by 236
Self-citationOxidative Stress in Radiation-Induced Cardiotoxicity
Ping, Z., Peng, Y., Lang, H., Xinyong, C., Zhiyi, Z., Xiaocheng, W., Hong, Z., & Liang, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3579143 · Cited by 187
“ROS activates NF-κB, which in turn increases the production of ROS by increasing the expression of COX-2 and 5-LPO [19].”
BackgroundInfluentialMiR‐21: A key player in glioblastoma pathogenesis
Masoudi, M. S., Mehrabian, E., & Mirzaei, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26300 · Cited by 163
Self-citationExosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
Self-citation
Metadata
- Authors
- Rashidi, B., Hoseini, Z., Sahebkar, A., & Mirzaei, H.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2017-04-10
- Volume
- 232
- Issue
- 11
- Pages
- 2968-2976
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2563509265
- Cited by
- 116
- References
- 19
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.